Emcure Pharmaceuticals Limited

-

Offer Period :

Emcure Pharmaceuticals Limited IPO Details

IPO Date - Minimum Investment ₹ / Lots
Listing Date Maximum Investment ₹ / Lots
Face Value ₹0 per share Total Issue Size ₹0 Crores
Price ₹0 to ₹0 per share Fresh Issue ₹0 Crores
Lot Size 1 Lots (0 Shares) Offer For Sale ₹ 0
Listing At Retail Discount ₹ 0
Employee Discount ₹ 0    
IPO Date -
Listing Date
Face Value ₹0 per share
Price ₹0 to ₹0 per share
Lot Size 1 Lots (0 Shares)
Listing At
Employee Discount ₹0 Crores
Minimum Investment ₹ / Lots
Maximum Investment ₹ / Lots
Total Issue Size ₹0 Crores
Fresh Issue ₹0 Crores
Offer For Sale
Retail Discount ₹ 0

Tentative Timeline

Important dates for allocation and IPO listing.

-

IPO Starts

-

IPO Ends

-

Allotment Date

-

Initiation of Refund

-

Credit of Shares to Demat Account

-

IPO Listing Date

Shareholder Pattern

  Pre-Issue Post-Issue
Promoter Group 0 0
Public Group 100 100

Emcure Pharmaceuticals Limited IPO Reservation

QIB Shares Offered 0(0%)
NII (HNI) Shares Offered 0(0%)
Retail Shares Offered 0(0%)
Anchor Investor Shares Offered 0(0%)
Total Shares Offered 0
Total Shares With Anchor Investor 0

IPO Lot Size

ApplicationLotsSharesAmount
Retail (Min)---
Retail (Max)---
S-HNI (Min)---
S-HNI (Max)---

Emcure Pharmaceuticals Limited IPO Registrar

Link Intime India Pvt Ltd
Phone Number +91 810 811 4949
Email Id emcure.ipo@linkintime.co.in
Our Website www.linkintime.co.in

Emcure Pharmaceuticals Limited IPO Lead Manager

1. Axis Capital Ltd

2. Kotak Mahindra Capital Company Ltd

3. Jefferies India Pvt Ltd

4. J.P. Morgan India Pvt Ltd

Explore IPOs


Explore comprehensive IPO details for every IPO. Access essential information such as listing price, listing date, issue price, lot size, issue size, minimum investment, and IPO timeline. Gain insights into the company's background, strengths, and potential risks. Track the subscription status and delve into the financials of the company, empowering yourself with crucial data for informed investment decisions. Stay ahead in the dynamic IPO market by staying informed on upcoming, ongoing, and past IPOs. 
 

Stay ahead in the ever-evolving IPO landscape with our comprehensive platform. We offer a holistic resource, ensuring you not only access essential details but also gain valuable insights into market trends. Navigate confidently, armed with intricate analyses, expert opinions, and real-time updates. Whether you're a seasoned investor or a novice, our user-friendly interface and extensive information empower you to make well-informed decisions. Experience the convenience of having a dedicated space where you can delve into the intricacies of IPOs, enabling a strategic and calculated approach to the dynamic stock market. 

Emcure Pharmaceuticals Limited IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid No. of subscribed

Strength of Emcure Pharmaceuticals Limited

1. Well-placed to leverage leading position in the domestic market.

2. Demonstrated capabilities of building brands.

3. Large, diversified and fast-growing product portfolio in international markets.

4. Strong R&D capabilities driving differentiated portfolio of products.

5. Extensive and diversified manufacturing capacity.

6. Highly qualified, experienced and entrepreneurial management team and our Board.

Risks Involved

1. Any manufacturing or quality control problems may damage its reputation, subject it to regulatory action, and expose it to litigation or other liabilities, which could adversely affect the company reputation, business, financial condition and results of operations.

2. Its failure to comply with applicable quality standards may result in product liability claims, which could adversely affect its business, financial condition, cash flows and results of operations.

3. Its manufacturing and research and development operations are subject to operational risks. Any slowdown or shutdown in its manufacturing or research and development operations could adversely affect its business, financial condition and results of operations.

4. The company is subject to extensive government regulations and if its fail to obtain, maintain or renew the company statutory and regulatory licenses, permits and approvals required to operate its business, the company's business, financial condition, results of operations and cash flows may be adversely affected.

5. Any disruptions to the supply, or increases in the pricing, of the raw materials and finished products that its outsource, may adversely affect the supply and pricing of its products and, in turn, adversely affect the company's business, cash flows, financial condition and results of operations.

6. The company has significant working capital requirements. If its experience insufficient cash flows to fund the company working capital requirements or if its not able to provide collateral to obtain letters of credit and bank guarantees in sufficient quantities, there may be an adverse effect on its business, financial condition, results of operations and cash flows.

7. If the company is unable to patent new processes, obtain trademarks for its products, or protect such proprietary information, its business may be adversely affected.

8. Its inability to meet the company obligations, including financial and other covenants under its debt financing arrangements could adversely affect its business, financial condition, results of operations and cash flows.

9. Its inability to accurately forecast demand for the company products and manage its inventory may have an adverse effect on the company business, financial condition, results of operations and cash flows.

10. There are outstanding legal proceedings involving the Company, its Directors, its Promoters, the company Subsidiaries and its Group Company, Heritage. Failure to defend these proceedings successfully may have an adverse effect on its business prospects, financial condition, results of ongoing operations and reputation.

Why should you invest in

-

Financials

Particulars For the financial year ending (in ₹ million)
  2023 2022 2021
Total Assets 6672.53 6063.47 6807.4
Total Liabilities 6672.53 6063.47 6807.4
Total Expenses 5278.35 4946.31 4222.13
Total Revenue 
6031.72 5918.86 5067.35
Profit After Tax 561.84 702.56 418.59
EBITDA 1220.94 1393.38 1245.63
Adjusted EBITDA 0 0 0

Emcure Pharmaceuticals Limited IPO Listing Details

Listing Date BSE Script Code NSE Symbol ISIN Final Issue Price
0 -
INE168P01015
₹0 per share

Listing Day Trading Information

Price Details BSE NSE
Final Issue Price ₹0 ₹0
Open ₹0 ₹0
Low ₹0 ₹0
High ₹0 ₹0
Low ₹0 ₹0

Frequently Asked Questions

What is Emcure Pharmaceuticals Limited IPO?

Answer Field

Emcure Pharmaceuticals Limited IPO is a [-] IPO of [-] equity shares of a face value of ₹[-] aggregating up to ₹[-] Crores. The issue is priced at ₹[-] to ₹[-] per share. The minimum order quantity is [-] Shares. The IPO opens on [-], and closes on [-]. Link Intime India Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on [-].

When Emcure Pharmaceuticals Limited IPO will open?

Answer Field

The Emcure Pharmaceuticals Limited IPO opens on [-] and closes on [-].

What is the lot size of Emcure Pharmaceuticals Limited?

Answer Field

Emcure Pharmaceuticals Limited lot size is [-] shares, and the minimum amount required is ₹[-].

How to apply for Emcure Pharmaceuticals Limited IPO?

Answer Field

You can apply in Emcure Pharmaceuticals Limited IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Emcure Pharmaceuticals Limited IPO allotment?

Answer Field

The finalization of Basis of Allotment for Emcure Pharmaceuticals Limited IPO will be done on [-], and the allotted shares will be credited to your demat account by [-].

When is Emcure Pharmaceuticals Limited IPO listing date?

Answer Field

The Emcure Pharmaceuticals Limited listing date is [-].

Who is the registrar of Emcure Pharmaceuticals Limited IPO?

Answer Field

The registrar of Emcure Pharmaceuticals Limited IPO is Link Intime India Pvt Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

Axis Capital Ltd,Kotak Mahindra Capital Company Ltd,Jefferies India Pvt Ltd,J.P. Morgan India Pvt Ltd will be the book-running lead manager of this IPO.

What is the fresh issue of Emcure Pharmaceuticals Limited IPO?

Answer Field

The fresh issue size is ₹[-] Crores equity shares.

What minimum lot size can retail subscribers subscribe to Emcure Pharmaceuticals Limited?

Answer Field

Retail investors can subscribe to a minimum of one lot, [-] shares and ₹[-] amount.

How can I approve the UPI mandate request for Emcure Pharmaceuticals Limited IPO?

Answer Field

To apply for Emcure Pharmaceuticals Limited IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Emcure Pharmaceuticals Limited?

Answer Field

The price of each Emcure Pharmaceuticals Limited share will be ranging in between ₹[-] to ₹[-] per share.

What is the cut-off time for the UPI mandate for Emcure Pharmaceuticals Limited IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, [-].

No results found

Browse IPOs

upcoming-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
current-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
closed-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
  • TBO TEK LIMITEDMainboard IPO

  • Bidding Dates

    8th May 2024 - 5th May 2024

  • Price Range

    ₹875 - 920

  • IPO Size

    ₹15,50,81,00,000

  • Invest Now
  • INDEGENE LIMITEDMainboard IPO

  • Bidding Dates

    6th May 2024 - 5th May 2024

  • Price Range

    ₹430 - 452

  • IPO Size

    ₹18,41,76,00,000

  • Invest Now

We have something for everyone

Explore more Investment options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Related Articles

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7 Lac+ Users

icon-with-text

4.3 App Rating

icon-with-text

4 Languages

icon-with-text

₹ 3800 Cr MTF Book

icon-with-text